Neonatal Encephalopathy Clinical Trials

14 recruitingLast updated: May 21, 2026

There are 14 actively recruiting neonatal encephalopathy clinical trials across 10 countries. Studies span Phase 2, Early Phase 1, Phase 3, Not Applicable. Top locations include Boston, Massachusetts, United States, San Diego, California, United States, Budapest, Hungary. Updated daily from ClinicalTrials.gov.


Neonatal Encephalopathy Trials at a Glance

14 actively recruiting trials for neonatal encephalopathy are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Boston, San Diego, and Budapest. Lead sponsors running neonatal encephalopathy studies include Boston Children's Hospital, Semmelweis University, and University of California, San Diego.

Browse neonatal encephalopathy trials by phase

About Neonatal Encephalopathy Clinical Trials

Looking for clinical trials for Neonatal Encephalopathy? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neonatal Encephalopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neonatal Encephalopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Healthy Little Eyes

Neonatal EncephalopathyEncephalopathyHypoxic-ischemic encephalopathy.
University of Wisconsin, Madison125 enrolled1 locationNCT05971446
Recruiting
Not Applicable

Neonate Cerebral Activity in Immediate Post Partum

Neonatal EncephalopathyAnoxia-Ischemia, Brain
Centre Hospitalier Universitaire, Amiens60 enrolled1 locationNCT04225975
Recruiting

Genetics of Neonatal Encephalopathy and Related Disorders

Neonatal EncephalopathyHypoxic Ischaemic Encephalopathy (HIE)
Boston Children's Hospital300 enrolled1 locationNCT07165938
Recruiting
Phase 3

Cooling in Mild Encephalopathy

Neonatal EncephalopathyNewborn Asphyxia
Imperial College London426 enrolled39 locationsNCT05889507
Recruiting
Phase 3

Neonatal Brain Ultrasound With CEUS and Elastography

Neonatal Hypoxic Ischemic EncephalopathyNeonatal StrokeNeonatal Encephalopathy, Unspecified
Turku University Hospital100 enrolled1 locationNCT05648812
Recruiting
Phase 2

Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy

Neonatal EncephalopathyNeonatal AsphyxiaHypoxic-ischemic encephalopathy.
Pharmazz, Inc.40 enrolled4 locationsNCT05514340
Recruiting

Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates

Preterm Less Than 32wks With IVH, WMI/PVLLate Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE
Brigham and Women's Hospital60 enrolled1 locationNCT07275021
Recruiting

Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

Neonatal EncephalopathyHypoxic Ischemic Brain Injury
Boston Children's Hospital125 enrolled3 locationsNCT02793999
Recruiting
Phase 2

A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

Neonatal EncephalopathyNeonatal SeizureSeizure Newborn+1 more
University of California, San Diego133 enrolled5 locationsNCT05610085
Recruiting

Neonatal Neurologic Intensive Care Network of China

Neonatal EncephalopathySuspected Neonatal Encephalopathy
Children's Hospital of Fudan University2,000 enrolled1 locationNCT02544100
Recruiting
Early Phase 1

Feasibility and Safety of Intranasally Administered Breast Milk in HIE

Neonatal EncephalopathyBrain InjuryHypoxic Ischemic Encephalopathy of Newborn+4 more
Semmelweis University10 enrolled1 locationNCT06747260
Recruiting

Natural History Study of Patients with HPDL Mutations

Neonatal EncephalopathyGenetic DiseaseMutation+4 more
University of California, San Diego50 enrolled1 locationNCT05848271
Recruiting
Phase 2

Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia

Neonatal Encephalopathy
Pia Wintermark60 enrolled2 locationsNCT06098833
Recruiting
Early Phase 1

Intranasal Breast Milk Therapy in HIE

Neonatal EncephalopathyNeonatal Hypoxic Ischemic EncephalopathyPerinatal Asphyxia+1 more
Semmelweis University80 enrolled1 locationNCT06746532